Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA.
Cell Death Differ. 2013 Nov;20(11):1465-74. doi: 10.1038/cdd.2013.52. Epub 2013 May 24.
DNA damage induced by reactive oxygen species and several chemotherapeutic agents promotes both p53 and poly (ADP-ribose) polymerase (PARP) activation. p53 activation is well known to regulate apoptotic cell death, whereas robust activation of PARP-1 has been shown to promote a necrotic cell death associated with energetic collapse. Here we identify a novel role for p53 in modulating PARP enzymatic activity to regulate necrotic cell death. In mouse embryonic fibroblasts, human colorectal and human breast cancer cell lines, loss of p53 function promotes resistance to necrotic, PARP-mediated cell death. We therefore demonstrate that p53 can regulate both necrotic and apoptotic cell death, mutations or deletions in this tumor-suppressor protein may be selected by cancer cells to provide not only their resistance to apoptosis but also to necrosis, and explain resistance to chemotherapy and radiation even when it kills via non-apoptotic mechanisms.
活性氧和几种化疗药物诱导的 DNA 损伤可促进 p53 和聚(ADP-核糖)聚合酶(PARP)的激活。众所周知,p53 的激活可调节细胞凋亡,而 PARP-1 的强烈激活已被证明可促进与能量衰竭相关的坏死性细胞死亡。在这里,我们确定了 p53 在调节 PARP 酶活性以调节坏死性细胞死亡中的新作用。在小鼠胚胎成纤维细胞、人结直肠癌细胞系和人乳腺癌细胞系中,p53 功能丧失会促进对坏死性、PARP 介导的细胞死亡的抵抗。因此,我们证明 p53 可以调节坏死性和细胞凋亡性细胞死亡,肿瘤抑制蛋白中的突变或缺失可能被癌细胞选择,不仅提供对细胞凋亡的抵抗,而且对坏死的抵抗,并且即使通过非细胞凋亡机制杀死,也可以解释对化疗和放疗的抵抗。